Skip to main content
SciBX
Feature Story

HemoShear's human touch

By Kai-Jye Lou, Senior Writer

HemoShear LLC's October announcement that a new application of its in vitro tissue modeling platform to tumors reproduces the human response to cisplatin means the company could soon tap into business from drug developers working in oncology-an area the biotech had not yet broached.

Since its launch in 2008, HemoShear has been engaging with client companies as well as partners from academia and the public sector to develop in vitro models of human tissue and organ systems to support drug discovery and understand disease biology. Its in vitro models include 3D culture systems and incorporate elements of in vivo physiology such as hemodynamic forces, multilayer biological transport processes and cell-to-cell communication.

Full Article

Sunshine Act

  • COVER STORY

    Tapping TOPK

    OncoTherapy Science has a potent TOPK inhibitor in a liposomal formulation that avoids the toxicity of other cytokinesis-targeted compounds.

  • TRANSLATIONAL NOTES

    Mixing it up at Karolinska

    Karolinska's new deputy vice chancellor, Alexander von Gabain, has plans to break down silos and breed new mindsets to maximize the institute’s translational potential.

  • TOOLS

    Paperback diagnostics

    A paper-based diagnostic using RNA switches could provide an easily distributed, rapid test for infectious diseases in point-of-care settings.

  • HemoShear's human touch

    HemoShear's in vitro tumor model shows a new application for its tissue modeling technology and could open it to business from oncology companies.

  • THERAPEUTICS

    This Week in Therapeutics

    Overcoming oncogenic KRAS-driven chemotherapy resistance by blocking NRF2 signaling; trifunctional arylpiperazine analogs as antipsychotic agents; inhibiting TRPM2 or RAC1 to treat ischemic kidney injury; and more...

  • TECHNIQUES

    This Week in Techniques

    Lysyl oxidase to enhance tensile properties of musculoskeletal grafts; a sorbitol-based PET imaging agent to help diagnose and monitor Enterobacteriaceae infections; genetic variants near estrogen receptor-alpha to predict the risk of breast cancer in Latina women; and more...

Subscribe Now
Free Trial